Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to 0.51.

  • Lifecore Biomedical, Inc. \De\'s Debt Ratio rose 2658.5% to 0.51 in Q2 2025 from the same period last year, while for May 2025 it was 0.51, marking a year-over-year increase of 2658.5%. This contributed to the annual value of 0.51 for FY2025, which is 2658.5% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Debt Ratio stood at 0.51 for Q2 2025, which was up 2658.5% from 0.49 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Debt Ratio ranged from a high of 0.51 in Q2 2025 and a low of 0.33 during Q2 2023
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Debt Ratio averaged around 0.39, with its median value being 0.38 (2021).
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 3656.78% in 2021, then soared by 2658.5% in 2025.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Debt Ratio stood at 0.39 in 2021, then dropped by 9.1% to 0.36 in 2022, then rose by 5.35% to 0.38 in 2023, then grew by 15.37% to 0.44 in 2024, then increased by 16.19% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q2 2025, 0.49 for Q1 2025, and 0.44 during Q4 2024.